tiprankstipranks
OncoArendi Therapeutics SA (PL:MOC)
:MOC
Poland Market
MOC
OncoArendi Therapeutics SA
RESEARCH TOOLSreports

OncoArendi Therapeutics SA (MOC) Income Statement

0 Followers

OncoArendi Therapeutics SA Income Statement

Last quarter (Q4 2025), OncoArendi Therapeutics SA's total revenue was zł0.00, a decrease of ― from the same quarter last year. In Q4, OncoArendi Therapeutics SA's net income was zł-1.73M. See OncoArendi Therapeutics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
zł 0.00zł 2.92Mzł 100.00zł 7.51Mzł 400.00
Gross Profit
zł 0.00zł -489.91Kzł -4.10Mzł -21.33Kzł -2.77M
Operating Expenses
zł 19.03Mzł 31.81Mzł 28.03Mzł 16.26Mzł 5.27M
Depreciation and Amortization
zł 3.01Mzł 3.82Mzł 2.83Mzł 3.98Mzł 299.82K
EBITDA
zł -19.03Mzł -27.37Mzł -25.51Mzł -31.85Mzł -13.33M
Operating Income
zł -22.04Mzł -33.61Mzł -32.13Mzł -43.91Mzł -13.76M
Other Income/Expenses
zł 6.35Mzł 2.32Mzł 3.75Mzł 7.96Mzł 127.98K
Pretax Income
zł -15.69Mzł -31.29Mzł -28.37Mzł -35.95Mzł -13.64M
Net Income
zł -15.69Mzł -31.29Mzł -28.37Mzł -13.54Mzł -13.64M
Per Share Metrics
Basic EPS
zł -0.77zł -1.55zł -1.69zł -2.56zł -0.98
Diluted EPS
zł -0.77zł -1.55zł -1.69zł -2.56zł -0.98
Weighted Average Shares Outstanding
 20.46M 20.20M 16.84M 14.03M 13.95M
Weighted Average Shares Outstanding (Diluted)
 20.46M 20.20M 16.84M 14.03M 13.95M
Currency in PLN

OncoArendi Therapeutics SA Earnings and Revenue History